Oscillating Magnet Array-Based Nanomagnetic Gene Transfection of Human Mesenchymal Stem Cells

• Cho HJ , LeeTS, ParkJBet al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J. Biochem. Mol. Biol. 40, 1069–1076 (2007).
   PubMedGoogle Scholar
• Kersting C , GebertC, AgelopoulosKet al. Epidermal growth factor receptor expression in high-grade osteosarcoma is associated with a good clinical outcome. Clin. Cancer Res. 13, 2998–3005 (2007).
   PubMed Web of Science ®Google Scholar
• Lamoureux F , RichardP, WittrantYet al. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockage of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res. 67, 7308–7318 (2007).
   PubMed Web of Science ®Google Scholar
• Nguyen LT , AtobeK, BarichelloJMet al. Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes. Biol. Pharm. Bull. 30, 751–757 (2007).
   PubMed Web of Science ®Google Scholar
• Park JS , NaK, WooDGet al. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 31, 124–132 (2012).
   Web of Science ®Google Scholar
• Lai Y , DrobinskayaI, KolossovEet al. Genetic modification of cells for transplantation. Adv. Drug Deliv. Rev. 60, 146–159 (2008).
   PubMed Web of Science ®Google Scholar
• Lu Y . Viral based gene therapy for prostate cancer. Curr. Gene Ther.1, 183–200 (2001).
   PubMedGoogle Scholar
• Bhattarai SR , KimSY, JangKYet al. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J. Virol. Methods 147, 213–218 (2008).
   PubMed Web of Science ®Google Scholar
• Verma IM . A tumultuous year for gene therapy. Mol. Ther.2, 415–416 (2000).
   PubMed Web of Science ®Google Scholar
• Spack EG , CorgiFL. Developing non-viral DNA delivery systems for cancer and infectious disease. Drug Disc. Today6, 186–197 (2001).
   PubMed Web of Science ®Google Scholar
• Mintzer MA , SimanekEE. Nonviral vectors for gene delivery. Chem. Rev.109, 259–302 (2009).
   PubMed Web of Science ®Google Scholar
• Pittenger MF , MackayAM, BeckSCet al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Chamberlain G , FoxJ, AshtonBet al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 25, 2739–2749 (2007).
   PubMed Web of Science ®Google Scholar
• Chen Y , ShaoJZ, XiangLXet al. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 40, 815–820 (2008).
   PubMed Web of Science ®Google Scholar
• Schop D , Dijkhuizen-RadersmaR, BorgartEet al. Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J. Tissue Eng. Regen. Med. 4, 131–140 (2009).
   Web of Science ®Google Scholar
• Mah C , ZolotukhinI, FraitesTJet al. Microsphere-mediated delivery of recombinant AVV vectors in vitro and in vivo. Mol. Ther. 1, S239 (2000).
   Google Scholar
• Mah C , FraitesTJ, ZolotukhinIet al. Improved method of recombinant AAV2 delivery for systemic targeted gene delivery. Mol. Ther. 6, 106–112 (2002).
   PubMed Web of Science ®Google Scholar
• Scherer F , AntonM, SchillingerUet al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102–109 (2002).
   PubMed Web of Science ®Google Scholar
• Plank C , SchillingerU, SchererFet al. The magnetofection method: using magnetic force to enhance gene delivery. Biol. Chem. 384, 737–747 (2003).
   PubMed Web of Science ®Google Scholar
• Krotz F , SohnHY, GloeTet al. Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vasc. Res. 40, 425–434 (2003).
   PubMed Web of Science ®Google Scholar
• Dobson J . Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther.13, 283–287 (2006).
   PubMed Web of Science ®Google Scholar
• Muthana M , ScottSD, FarrowNet al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 15, 902–910 (2008).
   PubMed Web of Science ®Google Scholar
• McBain SC , GriesenbachU, XenariouSet al. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnol. 19, 405102 (2008).
   PubMed Web of Science ®Google Scholar
• Pickard M , ChariD. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by ‘magnetofection‘: effects of static and oscillating fields. Nanomedicine5, 217–232 (2012).
   Web of Science ®Google Scholar
• Zhang Y , KohlerN, ZhangM. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials23, 1553–1561 (2002).
   PubMed Web of Science ®Google Scholar
• Dobson J . Magnetic micro and nano particle based targeting for drug and gene delivery. Nanomedicine1, 31–37 (2006).
   PubMed Web of Science ®Google Scholar
• Kim SJ , YoonTJ, YuKNet al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 89, 338–347 (2006).
   PubMed Web of Science ®Google Scholar
• McBain SC , YiuHHP, DobsonJ. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomedicine3, 169–180 (2008).
   PubMed Web of Science ®Google Scholar
• Fouriki A , ClementsMA, FarrowNet al. Efficient transfection of mg-63 osteoblasts using magnetic nanoparticles and oscillating magnet arrays. J. Tissue Eng. Regen. Med. doi: 10.1002/term.1508 (2012) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Furlani EP , XueX. A model for predicting field-directed particle transport in the magnetofection process. Pharm. Res.29(5), 1366–1379 (2012).
   PubMed Web of Science ®Google Scholar
• Furlani EP , XueX. Field, force and transport analysis for magnetic particle-based gene delivery. Microfluidics Nanofluidics13(4), 589–602 (2012).
   Web of Science ®Google Scholar
• Lim J , DobsonJ. Improved transfection of HUVEC and MEF cells using DNA complexes with magnetic nanoparticles in an oscillating field. J. Genet.91(2), 223–227 (2012).
   PubMed Web of Science ®Google Scholar
• Midoux P , PichonC, YaouancJJet al. Chemical vectors for gene delivery: a current review on polymers, peptides, and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 157, 166–178 (2009).
   PubMed Web of Science ®Google Scholar
• Fouriki A , FarrowN, ClementsMet al. Evaluation of the magnetic field requirements for nanomagnetic gene transfection. Nano Rev. doi: 10.3402/nano.v1i0.5167 (2010) (Epub ahead of print).
   PubMedGoogle Scholar

Patent

• Dobson J, Batich CD. Gene delivery. WO2006111770 (2005).
   Google Scholar